Q2 2024 Sensus Healthcare Inc Earnings Call Transcript
Key Points
- Sensus Healthcare Inc (SRTS) reported a strong year-over-year revenue growth of 104% for the second quarter of 2024, reaching $9.2 million.
- The company achieved positive net income of $1.6 million, compared to a net loss in the same quarter of the previous year.
- The Fair Deal Agreement program, launched in March, has gained traction with 15 signed contracts and expectations to reach up to 50 by year-end.
- International expansion efforts have been successful, with new sales in Asia, including the first-ever image-guided SRT-100 Vision system sold to Far Eastern Memorial Hospital in Taiwan.
- Gross profit margin improved to 58.7% in the second quarter of 2024, up from 57.9% in the same period of 2023.
- The company faces supply constraints due to high demand, with most Fair Deal Agreement installations expected in the fourth quarter.
- General and administrative expenses increased to $1.6 million in Q2 2024, primarily due to higher professional fees and compensation.
- Research and development expenses rose slightly, reflecting ongoing investment in new product development, such as the TransDermal Infusion (TDI) system.
- The FDA approval process for the TDI system has been delayed, requiring resubmission with additional features, potentially impacting the timeline for market entry.
- Cash and cash equivalents decreased to $19 million as of June 30, 2024, from $23.1 million at the end of 2023, indicating a reduction in liquidity.
Good day, and welcome for the Sensus Healthcare second-quarter 2024 financial results conference call. (Operator Instructions) Please note this event is being recorded. I would now like to turn the conference over to Kim Golodetz for opening remarks. Please go ahead.
Thank you. This is Kim Golodetz with LHA. Thank you all for participating in today's call. Joining me from Sensus Healthcare are Joe Sardano, Chairman and Chief Executive Officer; Michael Sardano, President and General Counsel and Javier Rampolla, Chief Financial Officer.
As a reminder, some of the matters that will be discussed during today's call contain forward-looking statements within the meaning of federal securities laws. All statements other than historical facts that address at, Sensus Healthcare assumes, plans, expects, believes, intends or anticipates and other similar expressions will, should or may occur in the future, are forward-looking statements. The forward-looking statements are management's beliefs based on currently available
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
